Home/Filings/4/0001062993-24-014792
4//SEC Filing

Rottinghaus Scott T. 4

Accession 0001062993-24-014792

CIK 0001177648other

Filed

Aug 8, 8:00 PM ET

Accepted

Aug 9, 5:24 PM ET

Size

9.6 KB

Accession

0001062993-24-014792

Insider Transaction Report

Form 4
Period: 2023-08-08
Rottinghaus Scott T.
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2023-08-08$17.23/sh1,467$25,27625,533 total
  • Tax Payment

    Common Stock

    2024-08-08$12.73/sh1,466$18,66218,784 total
Footnotes (2)
  • [F1]Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on August 8, 2022.
  • [F2]Such amount excludes securities acquired or disposed of subsequent to August 8, 2023.

Issuer

ENANTA PHARMACEUTICALS INC

CIK 0001177648

Entity typeother

Related Parties

1
  • filerCIK 0001942407

Filing Metadata

Form type
4
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 5:24 PM ET
Size
9.6 KB